Progress and promise: the current status of spinal muscular atrophy therapeutics

scientific article published on October 1, 2011

Progress and promise: the current status of spinal muscular atrophy therapeutics is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID22031667

P2093author name stringCharlotte J. Sumner
James P. Van Meerbeke
P433issue65
P407language of work or nameEnglishQ1860
P921main subjectspinal muscular atrophyQ580290
muscular atrophyQ2844600
P304page(s)291-305
P577publication date2011-10-01
P1433published inDiscovery MedicineQ5281940
P1476titleProgress and promise: the current status of spinal muscular atrophy therapeutics
P478volume12

Reverse relations

cites work (P2860)
Q34964785A cell system for phenotypic screening of modifiers of SMN2 gene expression and function
Q36199822Activin Receptor Type IIB Inhibition Improves Muscle Phenotype and Function in a Mouse Model of Spinal Muscular Atrophy
Q37320544Antisense oligonucleotide mediated therapy of spinal muscular atrophy
Q34608717Antisense therapy in neurology
Q34082155Assays for the identification and prioritization of drug candidates for spinal muscular atrophy
Q28730283Candidate proteins, metabolites and transcripts in the Biomarkers for Spinal Muscular Atrophy (BforSMA) clinical study
Q34505876Evaluation of peripheral blood mononuclear cell processing and analysis for Survival Motor Neuron protein
Q39992601FunMod: a Cytoscape plugin for identifying functional modules in undirected protein-protein networks
Q38197233Gem depletion: amyotrophic lateral sclerosis and spinal muscular atrophy crossover.
Q36302096Genetic inhibition of JNK3 ameliorates spinal muscular atrophy
Q39072801Genome-wide identification of mRNAs associated with the protein SMN whose depletion decreases their axonal localization
Q99603925Molecular mechanisms behind mRNA localization in axons
Q34658131SMA-MAP: a plasma protein panel for spinal muscular atrophy
Q37451229SMN is essential for the biogenesis of U7 small nuclear ribonucleoprotein and 3'-end formation of histone mRNAs.
Q36095048Small Molecules in Development for the Treatment of Spinal Muscular Atrophy
Q34460251Spinal Muscular Atrophy Therapeutics: Where do we Stand?
Q38070886Spinal muscular atrophy, John Griffin, and mentorship
Q35990221Spinal muscular atrophy: the role of SMN in axonal mRNA regulation.
Q36184477Spontaneous Breathing Pattern as Respiratory Functional Outcome in Children with Spinal Muscular Atrophy (SMA)
Q37193900The DcpS inhibitor RG3039 improves motor function in SMA mice.

Search more.